Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT02062294
Eligibility Criteria:
Inclusion Criteria:
* Liver transplant recipients, \>/= 16 years of age
* Transplantation between January 2004 and June 2009
* CMV seronegative recipient (R-) who received a liver transplant from a seropositive donor (D+)
* Valganciclovir therapy for at least 70 days beginning within 10 days post transplantation
* Assessment of CMV disease status within the first 6 months post transplantation
Exclusion Criteria:
* None
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT02062294
Study Brief:
Protocol Section:
NCT02062294